Pages that link to "Q51771177"
Jump to navigation
Jump to search
The following pages link to Pharmacological Characterization of Diethyl-2-({3-dimethylcarbamoyl-4-[(4′-trifluoromethylbiphenyl-2-carbonyl)amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein (Q51771177):
Displaying 16 items.
- Novel Abetalipoproteinemia Missense Mutation Highlights the Importance of the N-Terminal β-Barrel in Microsomal Triglyceride Transfer Protein Function (Q24338622) (← links)
- JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, reduces food preference for fat. (Q33737233) (← links)
- Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer (Q34785759) (← links)
- Gut-liver interaction in triglyceride-rich lipoprotein metabolism (Q37892758) (← links)
- Inhibition of cholesterol absorption: targeting the intestine. (Q38038125) (← links)
- New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? (Q38126418) (← links)
- Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition (Q38195808) (← links)
- Looking into the crystal ball-upcoming drugs for dyslipidemia (Q38235611) (← links)
- The role of microsomal triglyceride transfer protein inhibitors in the treatment of patients with familial hypercholesterolemia: risks, benefits, and management (Q38269470) (← links)
- Targeting fatty acid metabolism to improve glucose metabolism. (Q38548027) (← links)
- Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic rat (Q38628118) (← links)
- Targeting microsomal triglyceride transfer protein and lipoprotein assembly to treat homozygous familial hypercholesterolemia (Q38969073) (← links)
- Investigational therapies for hypercholesterolemia (Q39215123) (← links)
- JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats (Q39936507) (← links)
- Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide (Q45036032) (← links)
- JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats. (Q54385381) (← links)